thepapcorps_oitkp4

With the current pandemic, there are concerns about picking up COVID-19 from infected cough/sneeze droplets left on grocery store items, hand-delivered food/groceries, and take-out from local restaurants. Here are some simple tips to limit your exposure when bringing food and goods into your home from grocery stores and deliveries. When shopping, use a sanitizing wipe […]

Staying at home and preparing all of your meals is a challenge for many of us right now. But, if you’re also fighting cancer, this can be a particularly difficult time. At the Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, registered dietitians advise cancer patients on their food choices. Vitamins […]

Here are the photos from our Imagination Gala event, held on Thursday March 5th, 2020. It was a great success! Thank you so much for all the support! Click through the gallery below to see how this wonderful night turned out.

Diagnosed with the ravaging blood cancer acute myeloid leukemia (AML), Wellington’s Jerry Paull credits a drug called enasidenib that he says saved his life.

Game Changer Will Bring Cancer Information, Diagnosis to the Streets.

The Pap Corps Champions for Cancer Research [Pap Corps] and the University of Miami Sylvester Comprehensive Cancer Center, have joined efforts to address the increasingly high death rates for all types of treatable cancers in South Florida’s underserved communities.

Dr. Kevin Berkowitz Memorial End of Year Giving Campaign will help fund the purchase, retrofit and operation of Sylvester Comprehensive Cancer Center’s 3rd Game Changer Vehicle.
This air-conditioned RV will service medically underserved communities in north Broward and Palm Beach counties offering free cancer screenings, education and referrals, in addition to providing free medication to prevent HIV to at risk patients.

Sylvester joins a highly select group as one of only two NCI-designated cancer centers in the state of Florida, and one of just 71 across the nation.

Sylvester Comprehensive Cancer Center, part of the University of Miami Leonard M. Miller School of Medicine, has received the prestigious NCI designation from the National Cancer Institute.

In the battle to fight cancer, and to identify cures that not only save patients but also improve their quality of life, Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine and the Pap Corps, Champions for Cancer Research, have forged a remarkable partnership close to 70 years strong.

The feedback from our recent 65th Anniversary Gala Luncheon has been tremendous! From our venue, to the floral arrangements and our new video, we set the stage for our future growth.

The Board of Directors is pleased to announce that David Bakelman will be joining The Pap Corps as CEO on July 5th.
David has a rich history in growing nonprofits through his senior-level leadership over the past 15 years. Most recently David served as National CEO of HelpHOPELive, a Philadelphia-based national health organization which helps organ and cell transplant, spinal cord and traumatic brain injury patients raise funds to offset their medical expenses. HelpHOPELive is ranked in the top 1% of all charities in the United States. Previously, David served as President of the Magic Wand Foundation, an international youth empowerment charity and National CEO of StandUp For Kids, a non-profit serving homeless youth in 47 cities throughout the United States. For eight years David served as the Executive Director of Georgia Transplant Foundation, the largest human service organization in the country that provides financial assistance and advocacy to the organ transplant community.

George Papanicolaou, M.D., Ph.D. Statue Unvailing
The statue unveiled on Thursday, June 1, 2017 pays tribute to the legacy of Dr. Papanicolaou, a brilliant physician-scientist whose name will forever be linked with his life-saving contributions to the field of oncology. This memorial, located in the Schoninger Research Quadrangle outside of the Papnicolaou Cancer Research Building, was made possible through the generosity of the following donors: Eleni Anastasopoulos, Eleftheria Boubaris, Paula Dames, Velouthitsa Drymonis, Maria Ketsios, Evagelia Kolitsopoulos, Bill Mataragas, Marina Mazas, Fay Pavlopoulos, Lemonia Poumakis, Theodora Servos, Sylvia Stamatoglou

The terms “personalized medicine” and “precision medicine” are often used interchangeably; however, in the world of science, they’re not quite the same. Personalized medicine means developing a unique treatment plan for each patient. Precision medicine means developing treatment plans for groups of patients with similar conditions. Oncologists aspire to personalized medicine, but cancer is like snowflakes — each patient’s disease has its own unique mutations and other traits.

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine is launching Florida’s first oncology fellowship program developed for nurse practitioners. The announcement is being made during National Nurse Practitioners Week, November 13-19.

November has been an exciting month if you are a Florida Panthers fan or a cancer fighter or survivor. Sylvester Comprehensive Cancer Center has been honored to be the official Hockey Fights Cancer partner of the Panthers this year and announced a $25,000 donation for cancer research during a check presentation at the last Hockey Fights Cancer game on November 12.

A grassroots fundraising group that has been fighting cancer for six decades this week made its largest gift ever: $50 million to South Florida’s Sylvester Comprehensive Cancer Center.

The Pap Corps Champions for Cancer Research pledged to raise the money over 10 years to support the center’s research efforts. Sylvester is part of UHealth, the University of Miami‘s health care system.

The Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine announced on Thursday that the institution has received a $50 million pledge to fund cancer research.

“It’s one of the largest gifts to a cancer center in the nation this year,” Sylvester spokesman Patrick Bartosch told Patch immediately following the afternoon announcement.

Dorraya El-Ashry, Ph.D., breast cancer researcher at Sylvester Comprehensive Cancer Center and associate professor of medicine at the University of Miami Miller School of Medicine, as well as co-principal investigator Marc E. Lippman, M.D., Deputy Director of Sylvester and Kathleen & Stanley Glaser Professor at the Miller School, recently received a $126,000 grant from the Prevent Cancer Foundation to study the early detection of breast cancer metastasis. The grant will be paid out over one year.

Jeong Hee Cho-Vega, M.D., Ph.D., a skin cancer expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues have shown that a relatively simple, multi-step molecular diagnostic algorithm can help determine whether rare, atypical spitzoid tumors are benign spitz nevi or malignant melanomas. This new protocol could ensure that patients receive the right therapies to match the severity of their tumors. The study was published in the journal Modern Pathology.

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted a Cancer Moonshot Summit on June 29 as part of U.S. Vice President Joe Biden’s nationwide effort to make more therapies available to more patients, while also improving our ability to prevent cancer and detect it at an early stage. Across the country, hundreds of cancer centers, hospitals, and patient advocacy groups hosted summits – from Miami to Anchorage, Alaska.

UHealth – the University of Miami Health System is part of a cognitive imaging collaborative that will be using IBM’s Watson to bring cognitive imaging into daily practice to help physicians address some of the most challenging illnesses affecting the U.S. population. TheIBM Watson Medical Imaging Collaborative will be used to examine breast, lung, and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke.

Surrounded by firefighters, advocates and lawmakers, researchers at Sylvester Comprehensive Cancer Center announced that they are extending the Firefighters Cancer Initiative started nearly one year ago. The goal of the partnership between South Florida’s only academic-based cancer center and more than a dozen South Florida fire rescue departments is to better understand why firefighters may face a higher risk of cancer and find ways to improve their health and safety.

Clinical and epidemiological data have always pointed to eye cancer being more common among those individuals with light eye coloration and fair skin—however, the genetic mechanisms underlying disease development have been largely unknown. Now new research from investigators at The Ohio State University (OSU) and New York University (NYU) sheds light on specific inherited genetic differences for an increased risk of uveal melanoma, a rare cancer that arises from the pigment cells that determine eye color. 

The activity of two genes may help predict certain breast cancer patients’ chances of survival and guide their treatment, British researchers report. “We have seen major strides in the treatment of breast cancer, but once it begins to spread round the body it is still often fatal,” said Paul Workman. He is chief executive of the Institute of Cancer Research (ICR) in London, which conducted the research.

If you want to become involved in an effort that is truly saving lives, then join forces with Cancer Link, either as an individual committee member or as a community partner.

A new type of Nano bead, a medical magnetic bead, may offer better treatment for some liver cancers.  It’s called the LUMI bead and it lets doctors see in real time if the bead is delivered to the target. 

Over the past years, significant progress has been made in the fight against childhood cancer. Still, more than 15,000 young Americans under the age of 21 will be diagnosed with cancer this year, and more than 1,800 of them will not survive.

Ado-trastuzumab emtansine may provide meaningful benefit to patients with HER-2–positive metastatic breast cancer who underwent prior treatment with trastuzumab and pertuzumab, according to retrospective study results.

We talk a lot about the hardware that’s going to get us to Mars, but the most important things about human spaceflight is, well, humans! There’s a lot of research going into the impact space travel has on the body. Just think back to Scott Kelly’s year in space.